Hinge Health (NYSE:HNGE) CEO Sells $2,502,352.80 in Stock

Key Points

• Hinge Health CEO Daniel Antonio Perez sold 45,456 shares on May 7 at an average price of $55.05, totaling about $2.5 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and his ownership fell by 56.17%.
• The company reported strong quarterly results, with earnings of $0.45 per share versus the $0.12 consensus estimate and revenue of $182.31 million, up 47.2% year over year. Despite growth, Hinge Health still posted negative net margin and return on equity.
• Wall Street remains generally bullish on Hinge Health, with a consensus rating of “Moderate Buy” and an average price target of $67.40. Several firms raised targets after the earnings report, though one analyst downgraded the stock to hold.

Hinge Health Inc. (NYSE:HNGE - Get Free Report) CEO Daniel Antonio Perez sold 45,456 shares of the firm's stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $55.05, for a total value of $2,502,352.80. Following the sale, the chief executive officer owned 35,470 shares of the company's stock, valued at approximately $1,952,623.50. This trade represents a 56.17% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Daniel Antonio Perez also recently made the following trade(s):

• On Wednesday, May 6th, Daniel Antonio Perez sold 104,544 shares of Hinge Health stock. The shares were sold at an average price of $55.09, for a total value of $5,759,328.96.
• On Thursday, February 12th, Daniel Antonio Perez sold 166,665 shares of Hinge Health stock. The stock was sold at an average price of $40.26, for a total transaction of $6,709,932.90.

Hinge Health Price Performance

Shares of NYSE:HNGE traded up $0.89 during midday trading on Friday, reaching $55.89. The company had a trading volume of 1,861,078 shares, compared to its average volume of 1,251,254. The stock has a market capitalization of $4.40 billion and a P/E ratio of -4.53. The stock's fifty day moving average price is $42.81 and its 200-day moving average price is $44.00. Hinge Health Inc. has a one year low of $30.08 and a one year high of $62.18.

Hinge Health (NYSE:HNGE - Get Free Report) last announced its quarterly earnings data on Tuesday, May 5th. The company reported $0.45 earnings per share for the quarter, topping the consensus estimate of $0.12 by $0.33. The company had revenue of $182.31 million during the quarter. Hinge Health had a negative net margin of 78.95% and a negative return on equity of 279.39%. Hinge Health's revenue was up 47.2% on a year-over-year basis. During the same period in the prior year, the business earned $1.30 earnings per share. As a group, sell-side analysts forecast that Hinge Health Inc. will post 0.78 earnings per share for the current year.

Hedge Funds Weigh In On Hinge Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in HNGE. BIT Capital GmbH increased its position in Hinge Health by 79.3% in the 4th quarter. BIT Capital GmbH now owns 3,316,101 shares of the company's stock valued at $154,033,000 after acquiring an additional 1,466,577 shares during the period. Vanguard Group Inc. boosted its position in Hinge Health by 110.5% during the 4th quarter. Vanguard Group Inc. now owns 2,605,532 shares of the company's stock worth $121,027,000 after acquiring an additional 1,367,693 shares during the period. Tiger Global Management LLC grew its stake in shares of Hinge Health by 227.1% in the fourth quarter. Tiger Global Management LLC now owns 1,805,751 shares of the company's stock worth $83,877,000 after purchasing an additional 1,253,743 shares in the last quarter. Marshall Wace LLP acquired a new position in shares of Hinge Health during the fourth quarter valued at $54,469,000. Finally, Millennium Management LLC increased its holdings in shares of Hinge Health by 225.0% during the fourth quarter. Millennium Management LLC now owns 1,479,642 shares of the company's stock valued at $68,729,000 after purchasing an additional 1,024,317 shares during the period.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the company. Wall Street Zen downgraded Hinge Health from a "buy" rating to a "hold" rating in a report on Saturday, May 2nd. Raymond James Financial restated an "outperform" rating and set a $70.00 price objective on shares of Hinge Health in a research note on Wednesday. Citigroup reiterated an "outperform" rating on shares of Hinge Health in a research note on Wednesday. Barclays raised their price target on shares of Hinge Health from $52.00 to $62.00 and gave the stock an "overweight" rating in a research report on Wednesday. Finally, Citizens Jmp boosted their price objective on shares of Hinge Health from $65.00 to $80.00 and gave the company a "market outperform" rating in a research report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average price target of $67.40.

About Hinge Health

Hinge Health NYSE: HNGE is a digital musculoskeletal (MSK) clinic that provides end-to-end solutions for the prevention and management of musculoskeletal conditions. The company's platform combines wearable motion sensors, personalized exercise therapy guided by licensed physical therapists, and behavioral health coaching to deliver tailored treatment plans. By integrating technology with evidence-based clinical protocols, Hinge Health aims to reduce pain, improve mobility and decrease reliance on more invasive interventions such as surgery or opioid prescriptions.

Founded in 2015 and headquartered in San Francisco, Hinge Health partners with employers, health plans and other payers to offer its self-directed, app-based programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.